Abstract:Introduction NF-E2-related factor 2 (Nrf2), acts as a key transcription regulator in cytoprotection, is essential for the malignant biological behavior of cancer including proliferation, invasion, metastasis, and drug resistance. It has been reported that Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs in lung cancer, esophageal squamous cancer and breast cancer cells. In this study, we investigated the role of Nrf2 in terms of Hepatocellular Carcinoma (HCC) cells proliferation and drug resistance. Methods MTT colorimetric assay and flow cytometry were performed to investigate the sensitivity of different HCC cells including HepG2, Hep3B and SMCC-7721 to Cisplatin and Fluorouracil. Immunofluorescent assay was applied to detect the relationship between Nrf2-subcellular location and the chemotherapy sensitivity of HCC cells. Plasmids containing Nrf2-small interfering RNA (siRNA) or non-targeting vector control siRNA were transfected into HCC cells. The expression of Nrf2 was measured in HCC cells stably expressing Nrf2-siRNA by Western blots and RT-PCR assays, and the subcellular localization of Nrf2 was analyzed by immunofluorescent assay. To evaluate how the Nrf2 knockdown affected susceptibility to chemotherapeutic drugs, MTT and flow cytometry were done again in vitro. Results The susceptibility to chemotherapeutic drugs difference of all crowds was ordered from sensitivity to resistant as HepG2, Hep3B and SMCC-7721. Immunofluorescent assay showed that the distribution of Nrf2 in HCC cells markedly decreased in the cytoplasm and relatively increased in the nucleus with the decreased sensitivity. However, combination of Cisplatin or Fluorouracil and knock-out Nrf2 by siRNA significantly suppressed cell proliferation and increased cell apoptosis, especially in drug-resistant cells SMCC-7721. In SMCC-7721 cells, Nrf2-siRNA suppressed the nuclear transfer of Nrf2 induced by chemotherapy drugs resulted in enhancement of chemotherapy sensitivity. Conclusion Our findings provide evidences that Nrf2-siRNA acts as a chemotherapy-sensitizing agent to enhance the efficacy of chemotherapy and thus can be further used as an adjuvant treatment in chemotherapy of hepatocellular carcinoma.

Construction of RNA interfering expression vector directed against Nrf2

Inhibition of NRF2 Expression by RNAi in Caco-2 Cells

Construction of lentiviral vector of peroxiredoxin 2 gene mediating RNAi and its effects on the proliferation of SW480 cell

Construction of short hairpin RNA lentiviral vector targeting Nrf2 gene and its silencing effect on Nrf2 gene in HSC-T6 cells

Construction Of P53 Antisense Rna Expression Vector And Its Effect On Colon Cancer Cells

Construction of lentiviral vector of RNA interference and its effect on A549 and A549/DDP cells

Construction and Identification of the Small Interfering RNA Eukaryotic Expression Vectors of Human ClC-2 Gene

Construction and Identification of Two Psuper RNAi Systems of Inhibiting HIF -1Α Activity of Prostate Cancer

Construction of pRNAT-U6.1-siE2F3/Neo shRNA system to knockdown E2F3 gene activity

Bioengineered NRF2-siRNA is Effective to Interfere with NRF2 Pathways and Improve Chemosensitivity of Human Cancer Cells.

STUDY ON INHIBITION OF EXPRESSION OF HUMAN NUCLEAR RECEPTOR NR5A2 VIA RNA INTERFERENCE MEDIATED BY SIRNA EXPRESSING VECTOR

P-0079 Nrf2 Knockdown by Sirna Enhance the Sensitivity to Chemotherapy in Hepatocellular Carcinoma

Inhibiting Tumor Growth of Colorectal Cancer by Blocking the Expression of Vascular Endothelial Growth Factor Receptor 3 Using Interference Vector-Based RNA Interference

Construction of small interfering RNA expression vector targeting VEGFR-3 gene and its biologic effects

Construction of Expressing Vector of Psuper-Shrna/mrp1 and Its Expression in Vitro

Construction of eukaryotic expression vector of siRNA specific for hnRNP K and characterization of its efficiency in A549 lung carcinoma cell line

Inhibition of tumor growth of non-small cell lung cancer by small interfering RNA targeting to HER2/neu gene

The Role of Nrf2 in the Expression of UGT1A and Its Isoforms Induced by EGCG in Colon Tumor

Construction of pRNAT-U6.1/Neo siRNA System to Knockdown E2F-3 Activity

Construction of an Expression Vector Carrying Short Hairpin RNA Targeting Htert Gene and Its Effects on Breast Cancer Cell Telomerase Activity and Proliferation in Vivo

Construction of Sirna Expression Vectors for Human Telomerase Reverse Transcriptase and Their Inhibitory Effect on Transfected HeLa Cells in Vitro